Karen Sweiss

910 total citations
83 papers, 578 citations indexed

About

Karen Sweiss is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Karen Sweiss has authored 83 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hematology, 22 papers in Oncology and 19 papers in Genetics. Recurrent topics in Karen Sweiss's work include Multiple Myeloma Research and Treatments (39 papers), Hematopoietic Stem Cell Transplantation (25 papers) and Acute Myeloid Leukemia Research (21 papers). Karen Sweiss is often cited by papers focused on Multiple Myeloma Research and Treatments (39 papers), Hematopoietic Stem Cell Transplantation (25 papers) and Acute Myeloid Leukemia Research (21 papers). Karen Sweiss collaborates with scholars based in United States, China and South Africa. Karen Sweiss's co-authors include Pritesh Patel, Damiano Rondelli, Gregory S. Calip, Annie Oh, Nadim Mahmud, John G. Quigley, Santosh L. Saraf, Stacy S. Shord, David Peace and Irum Khan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Karen Sweiss

68 papers receiving 568 citations

Peers

Karen Sweiss
Frans J. Smiers Netherlands
Sunday Ocheni Nigeria
Deepesh Lad India
Sharon Avery Australia
Menaka Bhor United States
Hubert van Hoogstraten United States
Naeem Chaudhri Saudi Arabia
Aamer Aleem Saudi Arabia
Salvatore Leotta Italy
Victoria Latham United Kingdom
Frans J. Smiers Netherlands
Karen Sweiss
Citations per year, relative to Karen Sweiss Karen Sweiss (= 1×) peers Frans J. Smiers

Countries citing papers authored by Karen Sweiss

Since Specialization
Citations

This map shows the geographic impact of Karen Sweiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Sweiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Sweiss more than expected).

Fields of papers citing papers by Karen Sweiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Sweiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Sweiss. The network helps show where Karen Sweiss may publish in the future.

Co-authorship network of co-authors of Karen Sweiss

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Sweiss. A scholar is included among the top collaborators of Karen Sweiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Sweiss. Karen Sweiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sweiss, Karen, Sally A. Campbell‐Lee, Nadim Mahmud, et al.. (2025). Granulocyte colony‐stimulating factor may improve engraftment in adults with sickle cell disease undergoing non‐myeloablative haematopoietic stem cell transplantation. British Journal of Haematology. 207(4). 1690–1693.
3.
Sweiss, Karen, et al.. (2024). Haploidentical Peripheral Blood Stem Cell Transplantation in 20 Adult Patients with Sickle Cell Disease. Blood. 144(Supplement 1). 2101–2101.
4.
Mohyuddin, Ghulam Rehman, Jenny S. Guadamuz, Mustafa Ascha, et al.. (2024). Comparison of patients with myeloma receiving zoledronic acid vs denosumab: a nationwide retrospective cohort study. Blood Advances. 8(21). 5539–5541. 2 indexed citations
5.
Mohyuddin, Ghulam Rehman, Amandeep Godara, Brian McClune, et al.. (2024). ULTRA FRAIL-MM Clinical Trial: Go-Slow Approach Incorporating Isatuximab, Lenalidomide and Dexamethasone for Ultra-Frail Newly Diagnosed Myeloma. Blood. 144(Supplement 1). 6916–6916. 1 indexed citations
6.
Lee, Todd A., et al.. (2023). Perceptions of prescription opioids among marginalized patients with hematologic malignancies in the context of the opioid epidemic: a qualitative study. Journal of Cancer Survivorship. 18(4). 1285–1296. 1 indexed citations
7.
Poudyal, Bishesh Sharma, et al.. (2022). Hematopoietic Stem Cell Transplantation in Nepal: International Partnership, Implementation Steps, and Clinical Outcomes. Transplantation and Cellular Therapy. 28(5). 268–275. 8 indexed citations
8.
Zhou, Jifang, Karen Sweiss, Edith A. Nutescu, et al.. (2021). Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO Oncology Practice. 17(3). e294–e312. 9 indexed citations
9.
Han, Jin, Christopher Holden, Robert E. Molokie, et al.. (2020). Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease. British Journal of Haematology. 191(3). e70–e72. 4 indexed citations
10.
Patel, Pritesh, Vitalyi Senyuk, Karen Sweiss, et al.. (2020). PARP Inhibition Synergizes with Melphalan but Does not Reverse Resistance Completely. Biology of Blood and Marrow Transplantation. 26(7). 1273–1279. 9 indexed citations
11.
Calip, Gregory S., Pritesh Patel, Karen Sweiss, et al.. (2020). Targets of biologic disease‐modifying antirheumatic drugs and risk of multiple myeloma. International Journal of Cancer. 147(5). 1300–1305. 7 indexed citations
12.
Saraf, Santosh L., Pritesh Patel, Karen Sweiss, et al.. (2020). Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease. PLoS ONE. 15(2). e0229710–e0229710. 13 indexed citations
13.
Sweiss, Karen, Gregory S. Calip, Jeremy J. Johnson, Damiano Rondelli, & Pritesh Patel. (2019). Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma. Bone Marrow Transplantation. 54(12). 2081–2087. 6 indexed citations
14.
Sweiss, Karen, Annie Oh, Gregory S. Calip, Damiano Rondelli, & Pritesh Patel. (2019). Superior Survival in African American Patients Who Underwent Autologous Stem Cell Transplantation for Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(8). e506–e511. 9 indexed citations
15.
Sweiss, Karen, Jonathan Lee, Nadim Mahmud, et al.. (2019). Combined immune score of lymphocyte to monocyte ratio and immunoglobulin levels predicts treatment-free survival of multiple myeloma patients after autologous stem cell transplant. Bone Marrow Transplantation. 55(1). 199–206. 12 indexed citations
16.
17.
Sweiss, Karen, Gregory S. Calip, Annie Oh, Damiano Rondelli, & Pritesh Patel. (2018). Renal dysfunction within 90 days of FluBu4 predicts early and late mortality. Bone Marrow Transplantation. 54(7). 980–986. 5 indexed citations
18.
Mahmud, Nadim, Sujata Gaitonde, Benjamin J. Petro, et al.. (2018). Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model. PLoS ONE. 13(11). e0206980–e0206980. 2 indexed citations
19.
Sweiss, Karen, et al.. (2017). Collaborative Physician-Pharmacist Multiple Myeloma Clinic Improves Guideline Adherence and Prevents Treatment Delays. Blood. 130. 2112–2112. 1 indexed citations
20.
Sweiss, Karen, Jennifer M. Anderson, Annie Oh, et al.. (2017). A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant. Bone Marrow Transplantation. 53(3). 300–306. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frans J. Smiers Breakdown of academic impact, for papers by Sunday Ocheni Breakdown of academic impact, for papers by Deepesh Lad Breakdown of academic impact, for papers by Sharon Avery Breakdown of academic impact, for papers by Menaka Bhor Breakdown of academic impact, for papers by Hubert van Hoogstraten Breakdown of academic impact, for papers by Naeem Chaudhri Breakdown of academic impact, for papers by Aamer Aleem Breakdown of academic impact, for papers by Salvatore Leotta Breakdown of academic impact, for papers by Victoria Latham
Rankless by CCL
2026